Effect of intrastriatal mesenchymal stromal cell injection on progression of a murine model of Krabbe disease

Behavioural Brain Research

Volumn 225, Issue 2, 2011, Pages 415-425

  Wicks, Shawna E ^a   Londot, Heaven ^a   Zhang, Bo ^a,d   Dowden, Jennifer ^a   Klopf Eiermann, Jessica ^b   Fisher Perkins, Jeanne M ^b   Trygg, Cynthia B ^b   Scruggs, Brittni A ^c   Zhang, Xiujuan ^c   Gimble, Jeffrey M ^a   Bunnell, Bruce A ^b,c   Pistell, Paul J ^a,e  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e TOWSON UNIVERSITY   (United States)

Author keywords

Adipose derived stem stromal cells; Gait analysis; Krabbe disease; Mesenchymal stem stromal cells; Motor function; Twitcher mice

Indexed keywords

ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMATION; CELL THERAPY; CONTROLLED STUDY; COORDINATION; CORPUS STRIATUM; CRYOPROTECTION; DISEASE COURSE; FUNCTIONAL ASSESSMENT; GAIT; GENOTYPE; GLOBOID CELL LEUKODYSTROPHY; LIFESPAN; MESENCHYME CELL; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOTAXIC SURGERY; STRENGTH; STROMA CELL;

ANIMALS; ANIMALS, NEWBORN; CELL TRACKING; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GAIT; GENOTYPE; HUMANS; LEUKODYSTROPHY, GLOBOID CELL; MAZE LEARNING; MESENCHYMAL STROMAL CELLS; MICE; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; ROTAROD PERFORMANCE TEST;

EID: 80052968312     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.07.051     Document Type: Article

References (50)

1. Zlotogora J., Regev R., Hadar S., Iancu T.C. Growth pattern in Krabbe's disease. Acta Paediatr Scand 1986, 75:251-254.
2. D'Agostino A.N., Sayre G.P., Hayles A.B. Krabbe's disease. Globoid cell type of leukodystrophy. Arch Neurol 1963, 8:82-96.
3. Hagberg B., Sourander P., Svennerholm L. Diagnosis of Krabbe's infantile leucodystrophy. J Neurol Neurosurg Psychiatry 1963, 26:195-198.
4. Gullotta F., Pavone L., Mollica F., Grasso S., Valenti C. Krabbe's disease with unusual clinical and morphological features. Neuropadiatrie 1979, 10:395-400.
5. Sandhoff K. The biochemistry of sphingolipid storage diseases. Angew Chem Int Ed Engl 1977, 16:273-285.
6. Kobayashi T., Shinnoh N., Goto I., Kuroiwa Y. Hydrolysis of galactosylceramide is catalyzed by two genetically distinct acid beta-galactosidases. J Biol Chem 1985, 260:14982-14987.
7. Wenger D.A. Murine, canine and non-human primate models of Krabbe disease. Mol Med Today 2000, 6:449-451.
8. Svennerholm L., Vanier M.T., Mansson J.E. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. J Lipid Res 1980, 21:53-64.
9. Igisu H., Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 1984, 224:753-755.
10. Escolar M.L., Poe M.D., Provenzale J.M., Richards K.C., Allison J., Wood S., et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 2005, 352:2069-2081.
11. Caniglia M., Rana I., Pinto R.M., Fariello G., Caruso R., Angioni A., et al. Allogeneic bone marrow transplantation for infantile globoid-cell leukodystrophy (Krabbe's disease). Pediatr Transplant 2002, 6:427-431.
12. Kurtzberg J., Laughlin M., Graham M.L., Smith C., Olson J.F., Halperin E.C., et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996, 335:157-166.
13. Laughlin M.J., Eapen M., Rubinstein P., Wagner J.E., Zhang M.J., Champlin R.E., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004, 351:2265-2275.
14. Laughlin M.J., Barker J., Bambach B., Koc O.N., Rizzieri D.A., Wagner J.E., et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001, 344:1815-1822.
15. Duffner P.K., Caviness V.S., Erbe R.W., Patterson M.C., Schultz K.R., Wenger D.A., et al. The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York. Genet Med 2009, 11:450-454.
16. Lin D., Donsante A., Macauley S., Levy B., Vogler C., Sands M.S. Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy. Mol Ther 2007, 15:44-52.
17. Dolcetta D., Perani L., Givogri M.I., Galbiati F., Amadio S., Del Carro U., et al. Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain. J Gene Med 2006, 8:962-971.
18. Pellegatta S., Tunici P., Poliani P.L., Dolcetta D., Cajola L., Colombelli C., et al. The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation. Neurobiol Dis 2006, 21:314-323.
19. Shen J.S., Watabe K., Ohashi T., Eto Y. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements. Gene Ther 2001, 8:1081-1087.
20. Meng X.L., Shen J.S., Watabe K., Ohashi T., Eto Y. GALC transduction leads to morphological improvement of the twitcher oligodendrocytes in vivo. Mol Genet Metab 2005, 84:332-343.
21. Croitoru-Lamoury J., Williams K.R., Lamoury F.M., Veas L.A., Ajami B., Taylor R.M., et al. Neural transplantation of human MSC and NT2 cells in the twitcher mouse model. Cytotherapy 2006, 8:445-458.
22. Biswas S., Biesiada H., Williams T.D., LeVine S.M. Substrate reduction intervention by l-cycloserine in twitcher mice (globoid cell leukodystrophy) on a B6;CAST/Ei background. Neurosci Lett 2003, 347:33-36.
23. Biswas S., LeVine S.M. Substrate-reduction therapy enhances the benefits of bone marrow transplantation in young mice with globoid cell leukodystrophy. Pediatr Res 2002, 51:40-47.
24. Galbiati F., Givogri M.I., Cantuti L., Rosas A.L., Cao H., van Breemen R., et al. Combined hematopoietic and lentiviral gene-transfer therapies in newborn Twitcher mice reveal contemporaneous neurodegeneration and demyelination in Krabbe disease. J Neurosci Res 2009, 87:1748-1759.
25. Kagitani-Shimono K., Mohri I., Fujitani Y., Suzuki K., Ozono K., Urade Y., et al. Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model. J Neuroinflamm 2005, 2:10.
26. Pannuzzo G., Cardile V., Costantino-Ceccarini E., Alvares E., Mazzone D., Perciavalle V. A galactose-free diet enriched in soy isoflavones and antioxidants results in delayed onset of symptoms of Krabbe disease in twitcher mice. Mol Genet Metab 2010, 100:234-240.
27. Le Blanc K., Ringden O. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr Opin Immunol 2006, 18:586-591.
28. Le Blanc K., Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005, 11:321-334.
29. Puissant B., Barreau C., Bourin P., Clavel C., Corre J., Bousquet C., et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005, 129:118-129.
30. Ringden O., Uzunel M., Rasmusson I., Remberger M., Sundberg B., Lonnies H., et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006, 81:1390-1397.
31. Porada C.D., Zanjani E.D., Almeida-Porad G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther 2006, 1:365-369.
32. McIntosh K., Zvonic S., Garrett S., Mitchell J.B., Floyd Z.E., Hammill L., et al. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 2006, 24:1246-1253.
33. Yanez R., Lamana M.L., Garcia-Castro J., Colmenero I., Ramirez M., Bueren J.A. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006, 24:2582-2591.
34. Safford K.M., Hicok K.C., Safford S.D., Halvorsen Y.D., Wilkison W.O., Gimble J.M., et al. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 2002, 294:371-379.
35. Safford K.M., Safford S.D., Gimble J.M., Shetty A.K., Rice H.E. Characterization of neuronal/glial differentiation of murine adipose-derived adult stromal cells. Exp Neurol 2004, 187:319-328.
36. Ripoll C.B., Flaat M., Klopf-Eiermann J., Fisher-Perkins J.M., Trygg C.B., Scruggs B.A., et al. Mesenchymal-lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease. Stem Cells 2011, 29:67-77.
37. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
38. Suzuki K. The twitcher mouse. A model of human globoid cell leukodystrophy (Krabbe's disease). Am J Pathol 1983, 111:394-397.
39. Hoogerbrugge P.M., Poorthuis B.J., Romme A.E., van de Kamp J.J., Wagemaker G., van Bekkum D.W. Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse. J Clin Invest 1988, 81:1790-1794.
40. Yeager A.M., Brennan S., Tiffany C., Moser H.W., Santos G.W. Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse. Science 1984, 225:1052-1054.
41. Jacobs J.M., Scaravilli F., De Aranda F.T. The pathogenesis of globoid cell leucodystrophy in peripheral nerve of the mouse mutant twitcher. J Neurol Sci 1982, 55:285-304.
42. Taniike M., Suzuki K. Spacio-temporal progression of demyelination in twitcher mouse: with clinico-pathological correlation. Acta Neuropathol 1994, 88:228-236.
43. Terrell K.A., Rasmussen T.A., Trygg C., Bunnell B.A., Buck W.R. Molecular beacon genotyping for globoid cell leukodystrophy from hair roots in the twitcher mouse and rhesus macaque. J Neurosci Methods 2007, 163:60-66.
44. Ripoll C.B., Bunnell B.A. Comparative characterization of mesenchymal stem cells from eGFP transgenic and non-transgenic mice. BMC Cell Biol 2009, 10:3.
45. Pistell P.J., Ingram D.K. Development of a water-escape motivated version of the Stone T-maze for mice. Neuroscience 2010, 166:61-72.
46. Wooley C.M., Xing S., Burgess R.W., Cox G.A., Seburn K.L., Age, experience and genetic background influence treadmill walking in mice Physiol Behav 2009, 96:350-361.
47. Wooley C.M., Sher R.B., Kale A., Frankel W.N., Cox G.A., Seburn K.L. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 2005, 32:43-50.
48. Powell H.C., Knobler R.L., Myers R.R. Peripheral neuropathy in the Twitcher mutant. A new experimental model of endoneurial edema. Lab Invest 1983, 49:19-25.
49. Suzuki K. The twitcher mouse: a model for Krabbe disease and for experimental therapies. Brain Pathol 1995, 5:249-258.
50. Beare J.E., Morehouse J.R., DeVries W.H., Enzmann G.U., Burke D.A., Magnuson D.S., et al. Gait analysis in normal and spinal contused mice using the TreadScan system. J Neurotrauma 2009, 26:2045-2056.